Spermosens goal is to improve male fertility diagnostics and treatment through the introduction of ground breaking products. Spermosens first patented product JUNO-Checked measures the binding capacity between sperm and egg cell, which is a prerequisite for natural fertilization. The results are deemed to be able to help doctors choose the appropriate treatment method, which contributes to more successful IVF treatments, reduced suffering, and increased quality of life.
The WHO estimates that more than 48 million couples are affected by infertility, half of which is caused in whole or in part by a male factor. The company's shares are listed on Spotlight Stock market. The shares have ISIN code SE0015346424 and are traded under the short name SPERM. For more information, see www.spermosens.com
Company Details
- Employees
- 8
- Founded
- -
- Address
- The Spark, Medicon Village, Lund,skane County,sweden
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://www.spermosens.com
- Keywords
- HEI Therapeutics.
- HQ
- Lund, Skane County
Spermosens Ab Questions
Spermosens Ab's website is https://www.spermosens.com
Spermosens Ab's LinkedIn profile is https://se.linkedin.com/company/spermosens
Spermosens Ab has
8 employees.
View email and phone details for 8
employees at Spermosens Ab.
Spermosens Ab's industry is
Medical Equipment Manufacturing
Spermosens Ab's top competitors are
Sperm Analysis Technologies,
Hei Therapeutics,
Prolevi Bio,
H100,
Nested Bio Ab,
Umecrine Cognition Ab,
Lenshooke,
Diagonal Bio,
Roto Health Aps,
Fertipro Nv.
Spermosens Ab's categories are Medical Equipment Manufacturing
Spermosens Ab's founding year is 2018
